Upload
melih-bayar
View
9
Download
0
Tags:
Embed Size (px)
DESCRIPTION
food microbiology
Citation preview
www.helsinki.fi/yliopisto www.helsinki.fi/yliopisto
Campylobacter
Alejandra Culebro
Department of Food Hygiene and Environmental Health
Faculty of Veterinary Medicine
www.helsinki.fi/yliopisto
Campylobacteriosis
The genus Campylobacter
History
Taxonomy
Detection and isolation methods
Typing methods
Emerging campylobacters
Overview
www.helsinki.fi/yliopisto 30.10.2013 3 Source: National Institute for Health and Welfare 2011
0
10
20
30
40
50
60
70
80
90
2007 2008 2009 2010 2011
Co
nfi
rmed
cases p
er
100 0
00 p
op
ula
tio
n
Year
Average of EU member states except for Latvia, Portugal,Romania, and Slovenia
Finland
Source: EFSA 2009; EFSA 2010; EFSA 2011; EFSA and ECDC 2012; EFSA and ECDC 2013
Salmonella Campylobacter
www.helsinki.fi/yliopisto
Campylobacter
Source: THL
www.helsinki.fi/yliopisto Source: EFSA 2010; EFSA 2011
www.helsinki.fi/yliopisto 6
0
20
40
60
80
100
120
140
160
180
200
Fin EU US CR NewZealand
UK
www.helsinki.fi/yliopisto
500-800 cells
3.2 days
Self-limiting
Relapse 5-10%
Symptoms
Source: Black and others 1988; Feodoroff and others 2011; Pacanowski 2008; Skirrow 1977
Yet - Ingested dose
- Strains virulence - Acquired immunity
- Health status
www.helsinki.fi/yliopisto
Treatment and prevention
Treatment:
No treated
BUT:
Erythromycin (Acheson and Allos 2001; Taylor and Tracz 2005)
Macrolides, fluoroquinolones, and tetracyclines (Engberg and others 2001; Rapp 2007)
Antibiotic resistance (de Jong and others 2012)
Prevention:
Vaccine (?)
Control
www.helsinki.fi/yliopisto
Reservoirs and risk factors
www.helsinki.fi/yliopisto
So, what
about?
21.70%
75.8%, 10-10 000
CFU/g
www.helsinki.fi/yliopisto
- 28.11.2007-31.12.2007
- Cross-connection between
sewage- and drinking-water
pipelines
- 9500 residents: 50% ill
- 2052 healthcare visits
- Cost: EUR 354,496: EUR77/
patient
www.helsinki.fi/yliopisto
- Regurgitation
- Nausea
- Indigestion
- Heartburn
www.helsinki.fi/yliopisto
Sequels
Characteristics of post-campylobacteriosis-diseases.
Adapted from: Smith 2002; Kozminski 2008.
www.helsinki.fi/yliopisto
1886: Theodor Escherich: neonates
1913: McFadyean and Stockman: ovine foetuses
1963: Vibrio fetus and Vibrio bubulus Vibrio
1970s:
Filtration technique
Selective media
History of Campylobacter
Source: Charlier and others 1974; Ebruyned and others 2008; Kist 1986; McFadyean and Stockman 1913; Skirrow
1977; Skirrow 2006; Vron and Chatelain 1973
www.helsinki.fi/yliopisto 15
History of Campylobacter
By Joana Revez
www.helsinki.fi/yliopisto
Campylobacter
Source: Kaur and others 2011
Campylobacter coli, Gram-stain, 100X oil immersion
objective
www.helsinki.fi/yliopisto
Really? Another new
Campylobacter species?
Campylobacter iguaniorum (Maarten Gilbert, CDC)
Campylobacter fetus subsp. testudinum (Collette
Fitzgerald, CDC)
Campylobacter stanleyi (Lawson, UK)
New C. laninae-like Campylobacter species (Miller, USDA)
www.helsinki.fi/yliopisto
Challenges:
Low levels of contamination (Oyarzabal and others 2007)
VBNC (Chaisowwong and others 2012).
No Gold standard
Isolation and detection of
Campylobacter sp.
www.helsinki.fi/yliopisto
19
Isolation
Man, S. M. (2011) The clinical importance of emerging Campylobacter species
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2011.191. EFSA 2010; EFSA ; ECDC 2013; ISO 2006; ISO 2006
The ISO 10272-1:2006: Bolton for 4-6 h 37 C
FDA : pre-enrichment 4 h at 37 C or 3 h at 30 C +
2 h at 37 C. Enrichment 42 C for 20-44 h, and
streaking of 24 h and 48 h
The ISO 10272-1:2006: plating in mCCD agar and a 2nd
medium of own choice at 41.5 C for 40-48.
Microaerobic
www.helsinki.fi/yliopisto
www.helsinki.fi/yliopisto
Isolation methods drawbacks
Method of choice impacts the recovery of Campylobacter from food samples (Edson and others 2009).
Underestimation of prevalence (Oyarzabal and others 2013).
Cumulative 9-year false-negative rates (Edson and others 2009):
C. jejuni : 13.6%
C. coli is 24%
E. coli O157:H7: 7.8%
Salmonella spp. :5.9%
L. monocytogenes : 7.2
www.helsinki.fi/yliopisto
Gram-negative Nonsporeformers small spiral,
curved, or S-
shaped rods (0.20.8 m wide and 0.55.0 m long)
Microaerophilic
www.helsinki.fi/yliopisto
Common identification methods in
clinical samples Hip (-) Hip (+)
www.helsinki.fi/yliopisto 24
Who said there is only C. jejuni?
Fitzgerald, CHRO2013
CDC, USA
Presumptive
Campylobacter strains
(864), primarily hippurate
negative strains (2000-
2012)
48% No-C. jejuni/C. coli
www.helsinki.fi/yliopisto
Typing methods
Adapted from: Moore and others 2006
www.helsinki.fi/yliopisto
Typing methods
www.helsinki.fi/yliopisto
Typing methods
Phenotype
Penner: soluble
heat-stable
Lior: heat labile
antigens
Grow at 28 C
Hippurate
DNA hydrolysis
H2S production
Resistotyping tests
www.helsinki.fi/yliopisto
60 isolates
Serotyping
Penner and Hennessy: 89%, 10 serotypes
Lior and others: 45%, 8 serotypes
Biotyping
Skirrow and Benjamin: Cj: 2 biotypes
Roop and others: Cj: 2 biovars, Cc: 3
Lior: Cj: 2 biotypes, Cc: 2
Preston scheme: Cj: 7 biotypes, Cc: 18
Phage typing Preston: 3 phage groups
Khakhria and Lior: 3 phage groups
www.helsinki.fi/yliopisto
Typing methods
Genotype
MLST PFGE fla
www.helsinki.fi/yliopisto
70 C. coli: Humans (n=20) and retail meats (n=50)
61 PFGE profiles with SmaI and KpnI
MLST: 37 sequence types
www.helsinki.fi/yliopisto
MLST
Source: Sheppard and others 2013
www.helsinki.fi/yliopisto
Outbreak: Salinas, Kansas
www.helsinki.fi/yliopisto
Outbreak: Walkerton, ON
1346-2300 13
E.coli O157: H7
>30 Source: Barton and others 2007; Clark and others 2003
www.helsinki.fi/yliopisto
Virulence factors
fla
cdtB
LOS
www.helsinki.fi/yliopisto
WGS
www.helsinki.fi/yliopisto
Are non-jejuni/coli emerging
pathogens?
36
Allarmists Nonbelievers
YES NO
www.helsinki.fi/yliopisto
It is isolated more frequently:
1. It is the most frequent
enteric pathogen
2. The methods dont allow the correct
isolation/identification
of other cryptic -proteobacteria
Why we speak only about C.
jejuni?
37
Underestimation
Allarmists
Nonbelievers
www.helsinki.fi/yliopisto
Unknown etiology:
49% of the 1.7 million cases of foodborne diseases reported between 1996 and 2000 in England and Wales
(UK)
68% of 41,000 hospital diagnoses of gastroenteritis reported annually in Australia.
Campylobacter spp. other than C. jejuni/C. coli frequently be recovered from a substantial portion of
undiagnosed gastroenteritis cases.
38
Undiagnosed human
campylobacteriosis
Man, S. M. (2011) The clinical importance of emerging Campylobacter species
Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2011.191
www.helsinki.fi/yliopisto
Human diarrhoeic samples
C. jejuni
40%
Other Campylobacter spp.
50%
C. coli
3% C. fetus
3%
A. cryaerophilus
1%
A. butzleri
5%
39
Who said there is only C. jejuni?
Oleastro, CHRO2013
Portugal
(from September to
November 2012)
From 99/299 (33.2%)
stool samples of patients
with diarrhoea positive for
-proteobacteria
60% No-C. jejuni/C. coli
Higher in paediatric age
www.helsinki.fi/yliopisto 40
Who said there is only C. jejuni?
Bullman, 2011
Cork, Ireland
7194 patient faecal
samples submitted to the
Microbiology
Laboratory. January
2009 and December
2009.
349 (~5%) were
determined to be
Campylobacter
genus-positive 29% No-C. jejuni/C. coli
www.helsinki.fi/yliopisto www.helsinki.fi/yliopisto
Thank you
For the list of references please contact me at: [email protected]